[Retracted] Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

Figure 1

Development of two distinct molecular subtypes for R-CHOP-treated DLBCL patients. (a) A consensus matrix heat map when . The row and column of the matrix represent different samples. The values of the consensus matrix range from 0 (cannot be clustered together) to 1 (always clustered together) in white to dark blue. The consensus matrix is arranged in accordance with the consistency classification (the tree diagram above the heat map). (b) Cluster-consensus scores of the two molecular subtypes when . The higher the score, the higher the stability. (c) Kaplan-Meier overall survival analysis for patients in the two molecular subtypes. Red represents the subtype I group, and blue represents the subtype II group.

(a)

(b)

(c)